FDA Drug Application (020749) for LAMISIL by GLAXOSMITHKLINE CONS

Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Application Number020749
Product Number001
FormSOLUTION;TOPICAL
Dosage1%
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMISIL
Active IngredientTERBINAFINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TERBINAFINE2
List of drugs with Active Ingredient TERBINAFINE HYDROCHLORIDE3


Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS